chartexchange

ADIL
Adial Pharmaceuticals, Inc
stockNASDAQ

At CloseOct 28, 2026 3:59:41 PM EDT
5.10USD+37.466%(+1.39)83,211
After-hoursOct 28, 2026 4:54:30 PM EDT
5.001USD-1.941%(-0.099)
3.9500Bid5.5000Ask1.5500Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
Charlottesville, VA, USA
Previous Close
$3.71
Beta
0.87
52-Week High
$9.53 2025-10-28
52-Week Low
$1.31 2026-05-15
SMA 50
$4.76
SMA 200
$3.24
Avg. Vol 10D
20,845
Avg. Vol 30D
36,299
Avg. Vol 90D
54,421
Relative Vol
2.19
2.11M
62.0600%
667
Nov 12, 2026 (15d)
Feb 6, 2026 · 1-for-25 (reverse)
ADIL Profile

adial pharmaceuticals is dedicated to personalized treatment for drug abuse and addiction. while our pipeline includes drug candidates for the treatment of opiate and amphetamine use, our two lead drug candidates are for the treatment of alcohol abuse. adial leverages its extensive knowledge of pharmacology and pharmacogenomics to change the paradigm of drug abuse treatment.

ADIL Performance
PeriodPriceDateChangeBeta
1W4.112026-10-21+26.52%-1.801
1M4.042026-09-28+28.71%0.286
3M2.952026-07-28+76.27%-0.882
6M1.562026-04-28+233.33%0.566
1Y9.442025-10-28-44.89%0.869
2Y26.002024-10-28-80.00%—
5Y2,062.502021-10-28-99.75%0.691
ADIL Stock Summary

Adial Pharmaceuticals, Inc (NASDAQ:ADIL) stock price today is $5.20, and today's volume is 79,477. ADIL is up 40.162% today. The 30 day average volume is 36,299. ADIL market cap is $13.65M with 2.63M shares outstanding.